Commodore Capital’s Attovia Therapeutics ATTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$19.9M Buy
+1,160,000
New +$24.4M 1.54% 20

Other funds holding ATTO

Commodore Capital's ATTO Position: Q3 2026 in Review

Commodore Capital opened a new position in Attovia Therapeutics (ATTO) in Q3 2026: 1,160,000 shares worth $19.9M. The stake represents 1.54% of the portfolio and ranks #20 among its holdings.

57 funds tracked by Wall St. Rank hold ATTO as of Q3 2026.

  • Commodore Capital held 1,160,000 shares of Attovia Therapeutics worth $19.9M as of Q3 2026.
  • Attovia Therapeutics was a new Commodore Capital position in Q3 2026.
  • Attovia Therapeutics made up 1.54% of Commodore Capital's portfolio in Q3 2026, its #20 holding.
  • 57 funds tracked by Wall St. Rank held Attovia Therapeutics as of Q3 2026.

Based on Commodore Capital's 13F filing for Q3 2026, filed 16 Nov 2026.